|
16 Jul 2025 |
Cholamandalam
|
Consensus Share Price Target
|
1566.20 |
1628.12 |
- |
3.95 |
buy
|
|
|
|
|
30 Jun 2025
|
Cholamandalam
|
Sharekhan
|
1566.20
|
1900.00
|
1628.00
(-3.80%)
|
21.31 |
Buy
|
|
|
CIFC is expected to benefit from declining interest rates as the RBI has reduced repo rate by 100 bps over the last couple of quarters. The management expects a reduction of ~20–25 bps in cost of borrowings, hence improvement in NIM by ~10–15 bps in the current fiscal and some benefits would accrue in FY27.
|
|
29 Apr 2025
|
Cholamandalam
|
Motilal Oswal
|
1566.20
|
1770.00
|
1484.50
(5.50%)
|
13.01 |
Buy
|
|
|
Cholamandalam Inv. & Finance’s (CIFC) 4QFY25 PAT grew ~20% YoY to INR12.7b (in line). FY25 PAT grew ~24% YoY to INR42.6b. 4Q NII grew ~30% YoY to ~INR30.6b (in line). Other income grew ~26% YoY to ~INR7b (~9% beat), primarily driven by an upfront assignment income of ~INR940m.
|
|
29 Apr 2025
|
Cholamandalam
|
Axis Direct
|
1566.20
|
1780.00
|
1484.50
(5.50%)
|
13.65 |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
28 Apr 2025
|
Cholamandalam
|
ICICI Securities Limited
|
1566.20
|
1500.00
|
1525.80
(2.65%)
|
Target met |
Hold
|
|
|
Cholamandalam Finance’s (Chola) Q4FY25 performance was broadly in line with highest quarterly PBT-ROTA at 3.6% driven by 30bps QoQ NIM expansion, 10bps QoQ each credit cost and operating expense moderation.
|
|
28 Apr 2025
|
Cholamandalam
|
IDBI Capital
|
1566.20
|
1630.00
|
1525.80
(2.65%)
|
Target met |
Hold
|
|
|
|
|
01 Feb 2025
|
Cholamandalam
|
Motilal Oswal
|
1566.20
|
1475.00
|
1265.50
(23.76%)
|
Target met |
Buy
|
|
|
Cholamandalam Inv. & Finance (CIFC)’s 3QFY25 PAT grew ~24% YoY to INR10.9b (in line). NII grew ~33% YoY to ~INR28.9b (in line).
|
|
01 Feb 2025
|
Cholamandalam
|
Axis Direct
|
1566.20
|
1650.00
|
1265.50
(23.76%)
|
Target met |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
04 Nov 2024
|
Cholamandalam
|
Sharekhan
|
1566.20
|
1600.00
|
1251.25
(25.17%)
|
Target met |
Buy
|
|
|
CIFC reported net earnings of Rs. 963 crore, 3.5% (up 26.3%/2.2%, y-o-y/q-o-q) below estimates due to higher credit cost. Core PBT grew by 27.5% y-o-y/3.5% q-o-q, driven by AUM/NII growth. NIM, at 6.59% up 10 bps y-o-y, was in line with estimates.
|
|
29 Oct 2024
|
Cholamandalam
|
Edelweiss
|
1566.20
|
1530.00
|
1292.40
(21.19%)
|
Target met |
Buy
|
|
|
Steady growth but operating metrics softens
|
|
29 Oct 2024
|
Cholamandalam
|
IDBI Capital
|
1566.20
|
1560.00
|
1292.40
(21.19%)
|
Target met |
Buy
|
|
|
|
|
28 Oct 2024
|
Cholamandalam
|
Anand Rathi
|
1566.20
|
1601.00
|
1280.35
(22.33%)
|
Target met |
Buy
|
|
|
Driven by robust, 32% y/y, NII growth, Cholamandalam Investment &Finance’s Q2 net profit rose 25% y/y to Rs9.6bn.
|
|
17 Sep 2024
|
Cholamandalam
|
Sharekhan
|
1566.20
|
1850.00
|
1573.95
(-0.49%)
|
18.12 |
Buy
|
|
|
We maintain buy on Cholamandalam with a revised PT of Rs. 1,850 (valuing at 5.0x/4.0x of FY26E/ FY27E BV estimates). We believe strong growth outlook and superior profitability would support premium valuation.
|
|
29 Jul 2024
|
Cholamandalam
|
Motilal Oswal
|
1566.20
|
1675.00
|
1433.40
(9.26%)
|
Target met |
Buy
|
|
|
CIFC’s 1QFY25 PAT grew ~30% YoY to INR9.4b (in line). NII grew ~40% YoY to ~INR25.7b (in line). Other income grew ~62% YoY to~INR4.6b (6% beat).
|
|
29 Jul 2024
|
Cholamandalam
|
Edelweiss
|
1566.20
|
1650.00
|
1433.40
(9.26%)
|
Target met |
Buy
|
|
|
Steady AUM growth; PAT miss on higher credit cost
|
|
29 Jul 2024
|
Cholamandalam
|
IDBI Capital
|
1566.20
|
1362.00
|
1433.40
(9.26%)
|
Target met |
Buy
|
|
|
|
|
03 May 2024
|
Cholamandalam
|
Axis Direct
|
1566.20
|
1480.00
|
1309.70
(19.58%)
|
Target met |
Buy
|
|
|
Recommendation: We continue to maintain our BUY recommendation on the stock
|
|
02 May 2024
|
Cholamandalam
|
Anand Rathi
|
1566.20
|
1525.00
|
1301.60
(20.33%)
|
Target met |
Buy
|
|
|
Driven by the strong, 42% y/y, NII growth, Cholamandalam Investment and Finance’s Q4 net profit rose 25% y/y to Rs10.6bn.
|
|
02 May 2024
|
Cholamandalam
|
Sharekhan
|
1566.20
|
1500.00
|
1301.60
(20.33%)
|
Target met |
Buy
|
|
|
Cholamandalam Investment and Finance Company (CIFC) reported a strong overall performance in Q4FY2024, except for the elevated opex ratio. Core PBT grew 20% y-o-y/20% q-o-q, led by lower credit cost and higher NII/fee income offsetting the higher opex
|
|
02 May 2024
|
Cholamandalam
|
IDBI Capital
|
1566.20
|
1480.00
|
1301.60
(20.33%)
|
Target met |
Buy
|
|
|
|
|
30 Jan 2024
|
Cholamandalam
|
Motilal Oswal
|
1566.20
|
1470.00
|
1214.05
(29.01%)
|
Target met |
Buy
|
|
|
|